Lexaria Bioscience (LEXX) Long-Term Investments (2014 - 2026)

Lexaria Bioscience has disclosed Long-Term Investments across 6 years of filings, most recently posting $64014.0 for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $64014.0, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was $64014.0 (changed 0.0% YoY), and the FY2025 annual result was $64013.0, up 0.69% from the prior year.
• Long-Term Investments came in at $64014.0 for Q1 2026 at Lexaria Bioscience, roughly flat from $64013.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $64014.0 in Q4 2024 to a low of $48559.0 in Q3 2023.
• The 4-year median for Long-Term Investments is $64013.5 (2024), against an average of $62027.0.
• Across the five-year window, Long-Term Investments surged 30.92% in 2024 and dropped 0.0% in 2025, its largest moves.
• Lexaria Bioscience's Long-Term Investments stood at $48559.0 in 2023, then surged by 31.83% to $64014.0 in 2024, then fell by 0.0% to $64013.0 in 2025, then gained by 0.0% to $64014.0 in 2026.
• The last three Long-Term Investments figures came in at $64014.0 (Q1 2026), $64013.0 (Q4 2025), and $64013.0 (Q3 2025), per Business Quant data.